Search research articles
Contact Us
Filters
Showing results (141-150 of 187) with videos related to
Page
of 19
Sort By:
Radiation Oncology (London, England)
|
January 5, 2017
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov
Nikola Cihoric, Alexandros Tsikkinis, Giuseppe Minniti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 6, 2019
Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis
Jan Haussmann, Bálint Tamaskovics, Edwin Bölke, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients
David Pasquier, Brandon Barney, Santhanam Sundar, et al.
Theranostics
|
August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy
Giulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
International Journal of Cancer
|
February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer
Sebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Cancers
|
April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
April 29, 2021
Radiotherapy in nodal oligorecurrent prostate cancer
Michael Pinkawa, Daniel M Aebersold, Dirk Böhmer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)
Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 22, 2016
Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94)
Pirus Ghadjar, Christoph Pöttgen, Daniela Joos, et al.
World Journal of Urology
|
July 6, 2014
The oncologic role of local treatment in primary metastatic prostate cancer
Pirus Ghadjar, Alberto Briganti, Peter J L De Visschere, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 187) with videos related to
Sort By:
Page
of 19
Radiation Oncology (London, England)
|
January 5, 2017
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov
Nikola Cihoric, Alexandros Tsikkinis, Giuseppe Minniti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 6, 2019
Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis
Jan Haussmann, Bálint Tamaskovics, Edwin Bölke, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients
David Pasquier, Brandon Barney, Santhanam Sundar, et al.
Theranostics
|
August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy
Giulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
International Journal of Cancer
|
February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer
Sebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Cancers
|
April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
April 29, 2021
Radiotherapy in nodal oligorecurrent prostate cancer
Michael Pinkawa, Daniel M Aebersold, Dirk Böhmer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2022
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)
Constantinos Zamboglou, Simon K B Spohn, Juri Ruf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 22, 2016
Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94)
Pirus Ghadjar, Christoph Pöttgen, Daniela Joos, et al.
World Journal of Urology
|
July 6, 2014
The oncologic role of local treatment in primary metastatic prostate cancer
Pirus Ghadjar, Alberto Briganti, Peter J L De Visschere, et al.
Page
of 19